TickerFacts.

enGene Therapeutics Inc. (ENGN): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

51.12M
Year ended 2025-10-31
n/m
3-year compound annual growth
2022-10-31: 655.2K2023-10-31: 692.6K2024-10-31: 37.78M2025-10-31: 51.12M51.12M
2022-10-31 Weighted Average Diluted Shares (shares) 2025-10-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-10-3151.12M+35.3%2025-12-22, From 2024-11-01
2024-10-3137.78Mn/m2025-12-22, From 2023-11-01
2023-10-31692.6K+5.7%2024-12-19, From 2022-11-01
2022-10-31655.2Kn/a2024-01-29, From 2021-11-01